Patent details

Basic Information

Publication number:

EP1265929

PCT Application Number:

PCT/US/2001/009409

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019226299

PCT Publication Number:

WO/2001/070818

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-C2/C2A INHIBITORS OF COMPLEMENT ACTIVATION

French Title of Invention:

INHIBITEURS ANTI-C2/C2A D'ACTIVATION DE COMPLEMENT

German Title of Invention:

ANTI-C2/C2A INHIBITOREN ZUR KOMPLEMENT AKTIVIERUNG

SPC Number:

Dates

Filing date:

23/03/2001

Grant date:

08/07/2009

EP Publication Date:

08/07/2009

PCT Publication Date:

27/09/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/12/2002

EP B1 Publication Date:

08/07/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/03/2020

Expiration date:

23/03/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/03/2001

 

 

Name:

Genentech Inc.

Address:

1 DNA Way, South San Francisco, CA 94080, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

08/07/2009

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

SUN William, N.

Address:

United States (US)

2

Name:

SUN Cecily

Address:

United States (US)

3

Name:

FUNG Michael

Address:

United States (US)

Priority

Priority Number:

191429 P

Priority Date:

23/03/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 16/40;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

08/03/2019

Last Annual Fee Paid Number:

19

Last Annual Fee Paid Amount:

281 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages